Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion type Assertion NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_head.
- NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion description "[The aim of this study was to evaluate whether the neoadjuvant use of the dexamethasone (DEX) plus octreotide (OCT) regimen can improve the direct anticancer effects of docetaxel (DOC) in the TRAMP-C1 prostate cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_provenance.
- NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion evidence source_evidence_literature NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_provenance.
- NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion SIO_000772 22210719 NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_provenance.
- NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion wasDerivedFrom befree-20150227 NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_provenance.
- NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_assertion wasGeneratedBy ECO_0000203 NP358805.RAmwLThqwUNmJlrusKrZp9yHiJ7lR4cSUESjvUFu3SVjE130_provenance.